Suchergebnisse - "Yang, Soo-Ryum"

PubPharm (39)

1

Diffuse pleural mesotheliomas with genomic near-haploidization : a newly recognized subset with distinct clinical, histologic, and molecular features

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Yang, S. | Jayakumaran, G. | Benhamida, J. | +9

2

Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Yang, S. | Gedvilaite, E. | Ptashkin, R. | +16

3

Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2024

von Febres-Aldana, C. | Chang, J. | Jungbluth, A. | +15

4

Diffuse Pleural Mesothelioma : Advances in Molecular Pathogenesis, Diagnosis, and Treatment

enthalten in: Annual review of pathology | 2024

von Febres-Aldana, C. | Fanaroff, R. | Offin, M. | +4

5

RET-Altered Cancers-A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity

enthalten in: Cancers | 2023

von Desilets, A. | Repetto, M. | Yang, S. | +2

6

Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer

enthalten in: JCO precision oncology | 2023

von Thummalapalli, R. | Bernstein, E. | Herzberg, B. | +12

7

Response to Repotrectinib After Development of NTRK Resistance Mutations on First- and Second-Generation TRK Inhibitors

enthalten in: JCO precision oncology | 2023

von Chen, M. | Yang, S. | Shia, J. | +7

8

Rare molecular subtypes of lung cancer

enthalten in: Nature reviews. Clinical oncology | 2023

von Harada, G. | Yang, S. | Cocco, E. | +1

9

Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Choudhury, N. | Marra, A. | Sui, J. | +16

CommentIn: J Thorac Oncol. 2023 Apr;18(4):390-392. - PMID 36990569

10

Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2023

von Li, Y. | Yang, S. | Chen, Y. | +11